A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.

Autor:	Shibuya, Kazumoto1 (AUTHOR), Misawa, Sonoko1 (AUTHOR), Kimura, Hideki2 (AUTHOR), Noto, Yu-Ichi3 (AUTHOR), Sato, Yasunori4 (AUTHOR), Sekiguchi, Yukari1 (AUTHOR), Iwai, Yuta1 (AUTHOR), Mitsuma, Satsuki1 (AUTHOR), Beppu, Minako1 (AUTHOR), Watanabe, Keisuke1 (AUTHOR), Fujimaki, Yumi2 (AUTHOR), Tsuji, Yukiko3 (AUTHOR), Shimizu, Toshio2 (AUTHOR), Mizuno, Toshiki3 (AUTHOR), Nakagawa, Masanori3 (AUTHOR), Sawaguchi, Kyoko4 (AUTHOR), Hanaoka, Hideki4 (AUTHOR), Kuwabara, Satoshi1 (AUTHOR) kuwabara-s@faculty.chiba-u.jp
Zdroj:	Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Sep2015, Vol. 16 Issue 5/6, p353-358. 6p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.